Predictors of remission, erosive disease and radiographic progression in a Colombian cohort of early onset rheumatoid arthritis: a 3-year follow-up study
- 4 April 2016
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 35 (6) , 1463-1473
Abstract
The objective of the study is to find predictors of remission, radiographic progression (RP), and erosive disease in a cohort of patients with early onset rheumatoid arthritis (EORA) that followed a therapeutic protocol aiming at remission, in a real world tight-control setting. EORA patients were enrolled in a 3-year follow-up study. Clinical, biological, immunogenetic, and radiographical data were analyzed. Radiographs were scored according to Sharp–van der Heijde (SvdH) method. RP was defined by an increase of 3 units in 36 months. Remission was defined as DAS28 3 months, and presence of HLA-DRB1 shared epitope. Radiographic damage at baseline was the main predictor of outcomes. Autoantibodies, HAQ and ESR at baseline, symptom duration before diagnosis, and HLA-DRB1 status had influence on clinical course and development of structural joint damage in Colombian RA patients.Keywords
This publication has 45 references indexed in Scilit:
- The −308 G/A polymorphism in the tumor necrosis factor-α gene is not associated with development and progression of rheumatoid arthritis in Argentinean patientsInternational Journal of Rheumatic Diseases, 2014
- Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective studyAnnals of the Rheumatic Diseases, 2013
- Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDSRheumatology, 2011
- Associations between Human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort studyAnnals of the Rheumatic Diseases, 2008
- The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatmentArthritis & Rheumatism, 2005
- Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective studyAnnals of the Rheumatic Diseases, 2004
- Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable differenceArthritis & Rheumatism, 2002
- The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritisArthritis & Rheumatism, 2000
- A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort studyBMJ, 1996
- Association of HLA–DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup studyArthritis & Rheumatism, 1991